Priavoid’s oral Alzheimer’s drug falters on Phase II efficacy endpoint
The Phase II efficacy for Priavoid’s oral Alzheimer’s drug was not statistically significant but warrants further exploration.
The Phase II efficacy for Priavoid’s oral Alzheimer’s drug was not statistically significant but warrants further exploration.